Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Jan
31
2022
US Federal Labor Viewpoints – Week of January 24, 2022 Squire Patton Boggs (US) LLP
Jan
31
2022
Cannabis and District Courts: Are Those Courthouse Doors Closed Too? Squire Patton Boggs (US) LLP
Jan
28
2022
Beltway Buzz, January 28, 2022 Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Jan
28
2022
FDA Proposes Changes to FCN Program Bergeson & Campbell, P.C.
Jan
27
2022
New Tools in the Fight Against Counterfeit Pharmaceuticals Barnes & Thornburg LLP
Jan
27
2022
Medical Marijuana Program Oh So Close in Mississippi After House Sends Cannabis Legislation to Governor Bradley Arant Boult Cummings LLP
Jan
27
2022
FDA Enforcement Discretion for Agricultural Water Keller and Heckman LLP
Jan
26
2022
FDA Proposes Revising Regulations for Determining When an FCN is No Longer Effective Keller and Heckman LLP
Jan
26
2022
Prop 12 Enforcement Delayed for Some Stakeholders Keller and Heckman LLP
Jan
26
2022
Skinny Labels May Not Be Dead: Delaware District Court Distinguishes GSK, Dismisses Induced Infringement Claim Proskauer Rose LLP
Jan
26
2022
Instant Dismissal: Court Dismisses Instant Oatmeal Case against Whole Foods Market Proskauer Rose LLP
Jan
25
2022
Lawsuit Challenges Gerber Non-GMO Claim Keller and Heckman LLP
Jan
25
2022
OIG Approves Online Retailer’s Discount Program Mintz
Jan
25
2022
Acting New Jersey Attorney General Seeking Public Comment on the Use of Facial Recognition By Law Enforcement Squire Patton Boggs (US) LLP
Jan
25
2022
Phantom Participants with Real-World Ramifications: Clinical Drug Trial Data Falsification Tycko & Zavareei LLP
Jan
25
2022
Pot’s Progress in the Palmetto State Bradley Arant Boult Cummings LLP
Jan
24
2022
CMS Proposes Changes to Part D Regulations: Pharmacy Price Concessions Mintz
Jan
24
2022
FDA Clarifies Labeling Rules for Quantitative Claims About Sugar Keller and Heckman LLP
Jan
21
2022
Written Description Requirement Challenges: Federal Circuit Decision Sheds Light on How Expert Testimony Can Help Mintz
Jan
21
2022
Legal Considerations for Ready-to-Drink Cocktails McDermott Will & Emery
Jan
20
2022
EPA Announces New Endangered Species Act Protection Policy for New Conventional Pesticides Bergeson & Campbell, P.C.
Jan
20
2022
EPA Announces Proposed Rule to Update Several Pesticide Crop Groupings Bergeson & Campbell, P.C.
Jan
20
2022
Mississippi Medical Cannabis Act Rolls On: House Approves Amended Medical Cannabis Act with 104-14 Vote, Sending Act Back to the Senate Bradley Arant Boult Cummings LLP
Jan
20
2022
FDA Releases Report on 2021 Leafy Greens Outbreak Keller and Heckman LLP
Jan
20
2022
PLCB Approves Sales of CBD Products Norris McLaughlin P.A.
Jan
20
2022
DOT Random Drug and Alcohol Testing Rates for 2022 Jackson Lewis P.C.
Jan
19
2022
At-Home COVID-19 Testing Options and Alternatives Jackson Lewis P.C.
Jan
19
2022
Cargill Announces Planned Acquisition Of Croda’s Biobased Industrial Business Bergeson & Campbell, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins